> 0 1 0 1 O
/= 1 3 1 3 O
10 4 6 4 6 B-lower_bound
% 7 8 7 8 I-lower_bound
blasts 9 15 9 15 B-clinical_variable

A 0 1 16 17 O
negative 2 10 18 26 O
urine 11 16 27 32 B-pregnancy
pregnancy 17 26 33 42 I-pregnancy
test 27 31 43 47 O
is 32 34 48 50 O
required 35 43 51 59 O
within 44 50 60 66 O
1 51 52 67 68 B-upper_bound
week 53 57 69 73 I-upper_bound
for 58 61 74 77 O
all 62 65 78 81 O
women 66 71 82 87 B-gender
of 72 74 88 90 O
childbearing 75 87 91 103 O
potential 88 97 104 113 O
prior 98 103 114 119 O
to 104 106 120 122 O
enrolling 107 116 123 132 O
on 117 119 133 135 O
this 120 124 136 140 O
trial 125 130 141 146 O

Age 0 3 147 150 B-age
> 4 5 151 152 O
/= 5 7 152 154 O
60 8 10 155 157 B-lower_bound
years 11 16 158 163 I-lower_bound

Because 0 7 164 171 O
there 8 13 172 177 O
is 14 16 178 180 O
a 17 18 181 182 O
potential 19 28 183 192 O
risk 29 33 193 197 O
for 34 37 198 201 O
adverse 38 45 202 209 O
events 46 52 210 216 O
in 53 55 217 219 O
nursing 56 63 220 227 O
infants 64 71 228 235 O
secondary 72 81 236 245 O
to 82 84 246 248 O
treatment 85 94 249 258 B-treatment
of 95 97 259 261 O
the 98 101 262 265 O
mother 102 108 266 272 O
with 109 113 273 277 O
the 114 117 278 281 O
chemotherapy 118 130 282 294 B-treatment
agents 131 137 295 301 O
, 137 138 301 302 O
breastfeeding 139 152 303 316 O
should 153 159 317 323 O
also 160 164 324 328 O
be 165 167 329 331 O
avoided 168 175 332 339 O

ECOG 0 4 340 344 B-clinical_variable
performance 5 16 345 356 I-clinical_variable
status 17 23 357 363 I-clinical_variable
of 24 26 364 366 O
< 27 28 367 368 O
/= 28 30 368 370 O
2 31 32 371 372 B-upper_bound

IPSS 0 4 373 377 B-clinical_variable
> 5 6 378 379 O
/= 6 8 379 381 O
intermediate-2 9 23 382 396 O

Men 0 3 397 400 B-gender
and 4 7 401 404 O
women 8 13 405 410 B-gender
of 14 16 411 413 O
childbearing 17 29 414 426 O
potential 30 39 427 436 O
who 40 43 437 440 O
do 44 46 441 443 O
not 47 50 444 447 O
practice 51 59 448 456 O
contraception 60 73 457 470 O

Patient 0 7 471 478 O
with 8 12 479 483 O
documented 13 23 484 494 O
hypersensitivity 24 40 495 511 O
to 41 43 512 514 O
any 44 47 515 518 O
of 48 50 519 521 O
the 51 54 522 525 O
components 55 65 526 536 O
of 66 68 537 539 O
the 69 72 540 543 O
chemotherapy 73 85 544 556 B-treatment
program 86 93 557 564 O

Patients 0 8 565 573 O
aged 9 13 574 578 B-age
< 14 15 579 580 O
60 16 18 581 583 B-upper_bound
years 19 24 584 589 I-upper_bound
who 25 28 590 593 O
are 29 32 594 597 O
unsuitable 33 43 598 608 O
for 44 47 609 612 O
standard 48 56 613 621 O
induction 57 66 622 631 B-treatment
therapy 67 74 632 639 I-treatment
may 75 78 640 643 O
be 79 81 644 646 O
eligible 82 90 647 655 O
after 91 96 656 661 O
discussion 97 107 662 672 O
with 108 112 673 677 O
PI 113 115 678 680 O

Patients 0 8 681 689 O
with 9 13 690 694 O
history 14 21 695 702 O
of 22 24 703 705 O
MDS 25 28 706 709 B-cancer
transformed 29 40 710 721 O
to 41 43 722 724 O
AML 44 47 725 728 B-cancer
are 48 51 729 732 O
eligible 52 60 733 741 O
regardless 61 71 742 752 O
of 72 74 753 755 O
their 75 80 756 761 O
prior 81 86 762 767 B-treatment
therapy 87 94 768 775 I-treatment
for 95 98 776 779 O
MDS 99 102 780 783 O
provided 103 111 784 792 O

Patients 0 8 793 801 O
with 9 13 802 806 O
previously 14 24 807 817 O
untreated 25 34 818 827 O
AML 35 38 828 831 B-cancer
or 39 41 832 834 O
high 42 46 835 839 B-cancer
risk 47 51 840 844 I-cancer
MDS 52 55 845 848 I-cancer

Pregnant 0 8 849 857 B-pregnancy
women 9 14 858 863 B-gender

Prior 0 5 864 869 B-treatment
therapy 6 13 870 877 I-treatment
with 14 18 878 882 I-treatment
decitabine 19 29 883 893 I-treatment
will 30 34 894 898 O
be 35 37 899 901 O
allowed 38 45 902 909 O
unless 46 52 910 916 O
the 53 56 917 920 O
patient 57 64 921 928 O
experienced 65 76 929 940 O
progression 77 88 941 952 O
to 89 91 953 955 O
AML 92 95 956 959 B-cancer
while 96 101 960 965 O
being 102 107 966 971 O
treated 108 115 972 979 O
with 116 120 980 984 O
decitabine 121 131 985 995 O

Prior 0 5 996 1001 B-treatment
therapy 6 13 1002 1009 I-treatment
with 14 18 1010 1014 O
hydroxyurea 19 30 1015 1026 B-treatment
, 30 31 1026 1027 O
hematopoietic 32 45 1028 1041 B-treatment
growth 46 52 1042 1048 I-treatment
factors 53 60 1049 1056 I-treatment
, 60 61 1056 1057 O
azacytidine 62 73 1058 1069 B-treatment
, 73 74 1069 1070 O
ATRA 75 79 1071 1075 B-treatment
, 79 80 1075 1076 O
or 81 83 1077 1079 O
an 84 86 1080 1082 O
isolated 87 95 1083 1091 O
dose 96 100 1092 1096 O
of 101 103 1097 1099 O
cytarabine 104 114 1100 1110 B-treatment
up 115 117 1111 1113 O
to 118 120 1114 1116 O
2 121 122 1117 1118 B-upper_bound
g 122 123 1118 1119 I-upper_bound

Uncontrolled 0 12 1120 1132 O
intercurrent 13 25 1133 1145 B-chronic_disease
illness 26 33 1146 1153 I-chronic_disease

Women 0 5 1154 1159 B-gender
of 6 8 1160 1162 O
childbearing 9 21 1163 1175 O
potential 22 31 1176 1185 O
and 32 35 1186 1189 O
men 36 39 1190 1193 O
must 40 44 1194 1198 O
agree 45 50 1199 1204 B-contraception_consent
to 51 53 1205 1207 I-contraception_consent
use 54 57 1208 1211 I-contraception_consent
contraception 58 71 1212 1225 I-contraception_consent
prior 72 77 1226 1231 O
to 78 80 1232 1234 O
study 81 86 1235 1240 O
entry 87 92 1241 1246 O

cardiac 0 7 1247 1254 B-chronic_disease
arrhythmia 8 18 1255 1265 I-chronic_disease

kidney 0 6 1266 1272 O
function 7 15 1273 1281 O
( 16 17 1282 1283 O
creatinine 17 27 1283 1293 B-clinical_variable
< 28 29 1294 1295 O
/= 29 31 1295 1297 O
1.5 32 35 1298 1301 B-upper_bound
x 36 37 1302 1303 I-upper_bound
ULN 38 41 1304 1307 I-upper_bound
) 42 43 1308 1309 O

liver 0 5 1310 1315 O
function 6 14 1316 1324 O
( 15 16 1325 1326 O
bilirubin 16 25 1326 1335 B-clinical_variable
< 26 27 1336 1337 O
/= 27 29 1337 1339 O
2mg 30 33 1340 1343 B-upper_bound
/ 33 34 1343 1344 I-upper_bound
dL 34 36 1344 1346 I-upper_bound
, 36 37 1346 1347 O
AST 38 41 1348 1351 B-clinical_variable
and/or 42 48 1352 1358 O
ALT 49 52 1359 1362 B-clinical_variable
< 53 54 1363 1364 O
/=3 54 57 1364 1367 O
x 58 59 1368 1369 I-upper_bound
ULN 60 63 1370 1373 I-upper_bound
) 63 64 1373 1374 O

ongoing 0 7 1375 1382 O
or 8 10 1383 1385 O
active 11 17 1386 1392 O
uncontrolled 18 30 1393 1405 B-chronic_disease
infection 31 40 1406 1415 I-chronic_disease

psychiatric 0 11 1416 1427 B-chronic_disease
illness 12 19 1428 1435 I-chronic_disease
/ 19 20 1435 1436 I-chronic_disease
social 20 26 1436 1442 I-chronic_disease
situations 27 37 1443 1453 I-chronic_disease

symptomatic 0 11 1454 1465 O
congestive 12 22 1466 1476 B-chronic_disease
heart 23 28 1477 1482 I-chronic_disease
failure 29 36 1483 1490 I-chronic_disease

unstable 0 8 1491 1499 B-chronic_disease
angina 9 15 1500 1506 I-chronic_disease
pectoris 16 24 1507 1515 I-chronic_disease

